1. Home
  2. ABBV
  3. ABBV News

Latest AbbVie Inc. (ABBV) News on June 8, 2025

3 Stocks With Mouthwatering Dividends You Can Buy Right Now
ABBV

Motley Fool

11 hours ago

3 Stocks With Mouthwatering Dividends You Can Buy Right Now

Challenges pharma companies face in push into US manufacturing
ABBV

Yahoo Finance Video

2 days ago

Challenges pharma companies face in push into US manufacturing

Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?
ABBV

Zacks

2 days ago

Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?

AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
ABBV

Zacks

3 days ago

AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know

Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
ABBV

Motley Fool

3 days ago

Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks

AbbVie (ABBV): Buy, Sell, or Hold Post Q1 Earnings?
ABBV

StockStory

4 days ago

AbbVie (ABBV): Buy, Sell, or Hold Post Q1 Earnings?

Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks
ABBV

Zacks

4 days ago

Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks

3 Cheap Dividend Growth Stocks to Buy Right Now
ABBV

Motley Fool

4 days ago

3 Cheap Dividend Growth Stocks to Buy Right Now

ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons
ABBV

Clinical Trials Arena

5 days ago

ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons

AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals
ABBV

PR Newswire

5 days ago

AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals

AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
ABBV

PR Newswire

5 days ago

AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

High Growth Tech Stocks To Watch In The US June 2025
ABBV

Simply Wall St.

5 days ago

High Growth Tech Stocks To Watch In The US June 2025

ABBV

Argus Research

6 days ago

Weekly Stock List

AbbVie (ABBV) Gains As Market Dips: What You Should Know
ABBV

Zacks

9 days ago

AbbVie (ABBV) Gains As Market Dips: What You Should Know

AbbVie Partners with Chicago Cubs on "Striking Out Cancer"
ABBV

PR Newswire

9 days ago

AbbVie Partners with Chicago Cubs on "Striking Out Cancer"

ABBV

MT Newswires

9 days ago

Berenberg Adjusts Price Target on AbbVie to $170 From $195, Maintains Hold Rating

The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands
ABBV

Zacks

9 days ago

The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands

AbbVie’s ADC win shows how pharma can break through in solid tumors
ABBV

Pharma Voice

9 days ago

AbbVie’s ADC win shows how pharma can break through in solid tumors

Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical
ABBV

Zacks

10 days ago

Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical

AbbVie Stock Down Around 13% in 3 Months: Time to Buy the Dip?
ABBV

Zacks

10 days ago

AbbVie Stock Down Around 13% in 3 Months: Time to Buy the Dip?

AbbVie Inc. (ABBV)’s Pipeline Advances with Temab-A and ABBV-706, Shares Flat
ABBV

Insider Monkey

11 days ago

AbbVie Inc. (ABBV)’s Pipeline Advances with Temab-A and ABBV-706, Shares Flat

AbbVie (NYSE:ABBV) Showcases Promising Phase 1 ADC Results For Advanced Cancers
ABBV

Simply Wall St.

11 days ago

AbbVie (NYSE:ABBV) Showcases Promising Phase 1 ADC Results For Advanced Cancers

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?
ABBV

Zacks

11 days ago

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?

ABBV

PR Newswire

12 days ago

AbbVie Features New Data Across Difficult-to-Treat Solid Tumors and Blood Cancers at ASCO 2025, Highlighting Breadth and Depth of its Oncology Portfolio

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
ABBV

StockStory

13 days ago

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
ABBV

Motley Fool

16 days ago

U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result

Key Drivers Behind AbbVie’s (ABBV) Performance
ABBV

Insider Monkey

16 days ago

Key Drivers Behind AbbVie’s (ABBV) Performance

AbbVie Inc. (ABBV) Scores Major Legal Victory as Illinois Court Shuts Down $63 Billion Allergan Shareholder Lawsuit
ABBV

Insider Monkey

17 days ago

AbbVie Inc. (ABBV) Scores Major Legal Victory as Illinois Court Shuts Down $63 Billion Allergan Shareholder Lawsuit

AbbVie (NYSE:ABBV) Faces Legal Scrutiny Over Merger With Cerevel
ABBV

Simply Wall St.

17 days ago

AbbVie (NYSE:ABBV) Faces Legal Scrutiny Over Merger With Cerevel

AbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient
ABBV

CNW Group

17 days ago

AbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient

AbbVie (ABBV) has a Stable and Highly Profitable Business Model
ABBV

Insider Monkey

17 days ago

AbbVie (ABBV) has a Stable and Highly Profitable Business Model

3 Value Stocks Facing Headwinds
ABBV

StockStory

18 days ago

3 Value Stocks Facing Headwinds

2 Incredible Dividend Growth Stocks to Buy Now
ABBV

Motley Fool

18 days ago

2 Incredible Dividend Growth Stocks to Buy Now

ABBV

MT Newswires

19 days ago

Ameriprise Financial Initiates AbbVie at Buy

AbbVie (ABBV) Soared on Favorable Tailwinds
ABBV

Insider Monkey

19 days ago

AbbVie (ABBV) Soared on Favorable Tailwinds

Pfizer Signs Experimental Drug Licensing Agreement With 3SBio
ABBV

Zacks

19 days ago

Pfizer Signs Experimental Drug Licensing Agreement With 3SBio

The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie
ABBV

Zacks

20 days ago

The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie

Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
ABBV

Motley Fool

21 days ago

Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.

3 Magnificent Stocks That Are Passive Income Machines
ABBV

Motley Fool

22 days ago

3 Magnificent Stocks That Are Passive Income Machines

Jim Cramer On AbbVie: Makes “Sense To Start a Position in the Stock”
ABBV

Insider Monkey

23 days ago

Jim Cramer On AbbVie: Makes “Sense To Start a Position in the Stock”

Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New Deals
ABBV

Zacks

23 days ago

Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New Deals

1 Healthcare Stock to Keep an Eye On and 2 to Ignore
ABBV

StockStory

24 days ago

1 Healthcare Stock to Keep an Eye On and 2 to Ignore

FDA awards cancer drug approvals to AbbVie and MSD
ABBV

Pharmaceutical Technology

24 days ago

FDA awards cancer drug approvals to AbbVie and MSD

AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer
ABBV

Zacks

24 days ago

AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer

AbbVie stakes $335M on a startup’s RNAi drugs
ABBV

BioPharma Dive

24 days ago

AbbVie stakes $335M on a startup’s RNAi drugs

AbbVie expands siRNA push with $335m ADARx deal
ABBV

Pharmaceutical Technology

24 days ago

AbbVie expands siRNA push with $335m ADARx deal

FDA approves Roche’s MET protein expression detecting assay for NSQ-NSCLC
ABBV

Medical Device Network

25 days ago

FDA approves Roche’s MET protein expression detecting assay for NSQ-NSCLC

Regeneron Upgraded as AbbVie Catches Policy Heat
ABBV

GuruFocus.com

25 days ago

Regeneron Upgraded as AbbVie Catches Policy Heat

FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases
ABBV

Benzinga

25 days ago

FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases

ABBV

MT Newswires

25 days ago

AbbVie Says US FDA Approved Emrelis for Lung Cancer Indication

US FDA approves AbbVie's drug for a type of lung cancer
ABBV

Reuters

25 days ago

US FDA approves AbbVie's drug for a type of lung cancer

U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression
ABBV

PR Newswire

25 days ago

U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression

AbbVie Inc. (ABBV): Among the Best Dividend Growth Stocks with High Yields
ABBV

Insider Monkey

25 days ago

AbbVie Inc. (ABBV): Among the Best Dividend Growth Stocks with High Yields

ABBV

Investing.com

25 days ago

AbbVie, Merck cut to Neutral at Citi

ABBV

MT Newswires

25 days ago

AbbVie, ADARx Pharmaceuticals Launch Collaboration Focused on siRNA Therapies for Multiple Diseases

AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas
ABBV

PR Newswire

25 days ago

AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas

ABBV

MT Newswires

a month ago

Citigroup Downgrades AbbVie to Neutral From Buy, Adjusts Price Target to $205 From $210

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses
ABBV

StockStory

a month ago

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

Is AbbVie Inc. (ABBV) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?
ABBV

Insider Monkey

a month ago

Is AbbVie Inc. (ABBV) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?

ABBV

Thomson Reuters StreetEvents

a month ago

Q1 2025 Regenxbio Inc Earnings Call

Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared
ABBV

Zacks

a month ago

Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared

Trump's drug price order is part request, part threat: Analyst
ABBV

Yahoo Finance Video

a month ago

Trump's drug price order is part request, part threat: Analyst

S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'
ABBV

Investor's Business Daily

a month ago

S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'

How Trump could go about executing order to slash drug prices
ABBV

Yahoo Finance Video

a month ago

How Trump could go about executing order to slash drug prices

Trump expected to sign order to slash US drug prices
ABBV

Yahoo Finance Video

a month ago

Trump expected to sign order to slash US drug prices

US-China trade truce, April CPI, drug prices: 3 Things
ABBV

Yahoo Finance Video

a month ago

US-China trade truce, April CPI, drug prices: 3 Things

Recession Worries? Here's 1 of the Best Dividend Stocks for Turbulent Times
ABBV

Motley Fool

a month ago

Recession Worries? Here's 1 of the Best Dividend Stocks for Turbulent Times

2 High-Yield Dividend Stocks to Buy in May and Hold Forever
ABBV

Motley Fool

a month ago

2 High-Yield Dividend Stocks to Buy in May and Hold Forever

AbbVie Inc. (ABBV): Among the Best Income Stocks to Invest in Now
ABBV

Insider Monkey

a month ago

AbbVie Inc. (ABBV): Among the Best Income Stocks to Invest in Now

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks
ABBV

StockStory

a month ago

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

ABBV

MT Newswires

a month ago

BNP Paribas Exane Adjusts Price Target on AbbVie to $195 From $193, Maintains Neutral Rating

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates
ABBV

Zacks

a month ago

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates

Q1 Earnings Recap: AbbVie (NYSE:ABBV) Tops Therapeutics Stocks
ABBV

StockStory

a month ago

Q1 Earnings Recap: AbbVie (NYSE:ABBV) Tops Therapeutics Stocks

AbbVie Inc. (ABBV): A Bull Case Theory
ABBV

Insider Monkey

a month ago

AbbVie Inc. (ABBV): A Bull Case Theory

The Zacks Analyst Blog Highlights Johnson & Johnson and AbbVie
ABBV

Zacks

a month ago

The Zacks Analyst Blog Highlights Johnson & Johnson and AbbVie

Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better.
ABBV

The Wall Street Journal

a month ago

Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better.

If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now?
ABBV

Benzinga

a month ago

If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now?

JNJ vs. ABBV: Which Pharma Powerhouse Has Better Growth Prospects?
ABBV

Zacks

a month ago

JNJ vs. ABBV: Which Pharma Powerhouse Has Better Growth Prospects?

AbbVie to Present at the Bank of America Securities Healthcare Conference
ABBV

PR Newswire

a month ago

AbbVie to Present at the Bank of America Securities Healthcare Conference

ChatGPT Stock Advice: AbbVie Inc. (ABBV) Among Top Stock Recommendations
ABBV

Insider Monkey

a month ago

ChatGPT Stock Advice: AbbVie Inc. (ABBV) Among Top Stock Recommendations

On tariffs and pricing, Big Pharma CEOs are waiting out the storm while planning for the worst
ABBV

Pharma Voice

a month ago

On tariffs and pricing, Big Pharma CEOs are waiting out the storm while planning for the worst

1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar
ABBV

StockStory

a month ago

1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
ABBV

Motley Fool

a month ago

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?

AbbVie Stock: Using A Long-Term Leap Ratio Spread On This Pharma Giant
ABBV

Investor's Business Daily

a month ago

AbbVie Stock: Using A Long-Term Leap Ratio Spread On This Pharma Giant

Transforming HR Leadership: Inside The Darla Moore School’s Standout MHR Program
ABBV

Poets & Quants

a month ago

Transforming HR Leadership: Inside The Darla Moore School’s Standout MHR Program

BOTOX® Cosmetic (onabotulinumtoxinA) Continues its Mission of Empowering Entrepreneurs Through "The Confidence Project"
ABBV

PR Newswire

a month ago

BOTOX® Cosmetic (onabotulinumtoxinA) Continues its Mission of Empowering Entrepreneurs Through "The Confidence Project"

ABBV

Argus Research

a month ago

Market Digest: BKNG, AMT, SBUX, MSCI, DLR, ABBV, QRVO, SNAP

ABBV

Argus Research

a month ago

Analyst Report: AbbVie Inc

ABBV

Argus Research

a month ago

Market Digest: BKNG, AMT, SBUX, MSCI, DLR, ABBV, QRVO, SNAP

High Growth Tech Stocks In The US Market April 2025
ABBV

Simply Wall St.

a month ago

High Growth Tech Stocks In The US Market April 2025

FDA approves AbbVie’s upadacitinib for giant cell arteritis
ABBV

Pharmaceutical Technology

a month ago

FDA approves AbbVie’s upadacitinib for giant cell arteritis

Moderna (MRNA) Reports Earnings Tomorrow: What To Expect
ABBV

StockStory

a month ago

Moderna (MRNA) Reports Earnings Tomorrow: What To Expect

Amgen (AMGN) Reports Earnings Tomorrow: What To Expect
ABBV

StockStory

a month ago

Amgen (AMGN) Reports Earnings Tomorrow: What To Expect

Biogen Earnings: What To Look For From BIIB
ABBV

StockStory

a month ago

Biogen Earnings: What To Look For From BIIB

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q1 Earnings
ABBV

StockStory

a month ago

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q1 Earnings

AbbVie (NYSE:ABBV) Receives FDA Approval For RINVOQ In Treating Giant Cell Arteritis
ABBV

Simply Wall St.

a month ago

AbbVie (NYSE:ABBV) Receives FDA Approval For RINVOQ In Treating Giant Cell Arteritis

ABBV

MT Newswires

a month ago

AbbVie Says Rinvoq Medication Gets FDA Approval to Treat Giant Cell Arteritis

ABBV

MT Newswires

a month ago

Guggenheim Adjusts AbbVie Price Target to $216 From $214, Maintains Buy Rating

RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)
ABBV

PR Newswire

a month ago

RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)

ABBV

Argus Research

a month ago

Technical Assessment: Neutral in the Intermediate-Term

Share on Social Networks: